Volume 23 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2025  >  23(11): 1882-1884
XIA Hongyun, XU Na, LIU Chao. Correlation among self-efficacy, self-management behavior and outcome in patients with dilated cardiomyopathy[J]. Chinese Journal of General Practice, 2025, 23(11): 1882-1884. doi: 10.16766/j.cnki.issn.1674-4152.004251
Citation: XIA Hongyun, XU Na, LIU Chao. Correlation among self-efficacy, self-management behavior and outcome in patients with dilated cardiomyopathy[J]. Chinese Journal of General Practice, 2025, 23(11): 1882-1884. doi: 10.16766/j.cnki.issn.1674-4152.004251
shu

Correlation among self-efficacy, self-management behavior and outcome in patients with dilated cardiomyopathy

doi: 10.16766/j.cnki.issn.1674-4152.004251

  • Department of Cardiology, Qingdao Municipal Hospital, Qingdao, Shandong 266071, China

Funds:

 202203010192

  • Received Date: 2025-03-11
    Available Online: 2026-01-07
    Abstract
  •   Objective  To explore the correlation among self-efficacy, self-management behavior and prognosis in patients with dilated cardiomyopathy (DCM), in order to further improve the prognosis of DCM.  Methods  Two hundred patients with DCM admitted to Qingdao Municipal Hospital from January 2021 to December 2022 were selected as the research objects and divided into death group and survival group according to the follow-up results. The scores of the general self-efficacy scale (GSES) and the "questionnaire on self-management ability of DCM treatment patients" of the patients were collected through the questionnaire survey method, and the Spearman correlation analysis method was used to study the relationship between them and the prognosis of the disease.  Results  Comparison of GSES assessment results, the self-efficacy of symptom management [(10.88±2.50) points], the score of disease commonality management self-efficacy [(14.84±2.01) points] and the total score of GSES [(25.72±5.96) points] in the survival group were all higher than those in the death group [(7.88±1.92) points, (11.27±3.06) points, (19.15±6.02) points, P < 0.05]. The comparison of self-management behaviors showed that the scores of each sub-scale and the total score were all higher than those of the death group (P < 0.05). Symptom management self-efficacy (r=0.482), disease commonality management self-efficacy (r=0.360), total score of GSES (r=0.423), medication compliance (r=0.650), diet management (r=0.314), complication prevention (r=0.897), disease surveillance (r=0.632), and total score of self-management behavior (r=0.625) were all positively correlated with the prognosis of DCM (P < 0.05).  Conclusion  The self-efficacy and self-management behavior of DCM patients are closely related to the prognosis and improving patients ' self-efficacy and self-management behavior of DCM patients may be conducive to improving the prognosis.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    张舒媛, 高仕奇, 王泽源, 等. 扩张型心肌病患者长期预后及危险因素分析[J]. 中华心血管病杂志, 2024, 52(4): 384-390.

    ZHANG S Y, GAO S Q, WANG Z Y, et al. Analysis of long-term prognosis and risk factors in patients with dilated cardiomyopathy[J]. Chinese Journal of Cardiology, 2024, 52(4): 384-390.
    [2]
    胡盛惠, 姚立影, 魏薇, 等. β1受体阻滞剂防治脓毒症心肌病作用的研究进展[J]. 中国临床新医学, 2024, 17(2): 227-232.

    HU S H, YAO L Y, WEI W, et al. Research progress in the effect ofβ1-receptor blockers on prevention and treatment of sepsis-induced cardiomyopathy[J]. Chinese Journal Of New Clinical Medicine, 2024, 17(2): 227-232.
    [3]
    邱月清, 王振涛, 陈振翼, 等. 调节性细胞死亡在扩张型心肌病中的研究进展[J]. 中国比较医学杂志, 2024, 34(5): 113-125.

    QIU Y Q, WANG Z T, CHEN Z Y, et al. Research progress on the relationship between regulatory cell death and dilated cardiomyopathy[J]. Chinese Journal of Comparative Medicine, 2024, 34(5): 113-125.
    [4]
    邱清勇, 彭锦, 刘大勇. 基线HE4水平对扩张型心肌病患者药物治疗反应性的评估[J]. 心脏杂志, 2023, 35(3): 310-315.

    QIU Q Y, PENG J, LIU D Y. Evaluation of baseline HE4 levels and drug therapy responsiveness in patients with dilated cardiomyopathy[J]. Chinese Heart Journal, 2023, 35(3): 310-315.
    [5]
    沈月英, 王楠, 张玥. 心肌收缩力调节器的研究进展[J]. 新医学, 2023, 54(4): 250-253.

    SHEN Y Y, WANG N, ZHANG Y. Cardiac contractility modulator: new hope for heart failure patients[J]. Journal of New Medicine, 2023, 54(4): 250-253.
    [6]
    唐妙, 胡永奎. 以智谋理论为框架的协同干预对ST段抬高型心肌梗死介入治疗后患者反刍性沉思及自我效能感的影响[J]. 中国医药导报, 2024, 21(10): 167-171.

    TANG M, HU Y K. Effects of collaborative intervention with the framework of resourcefulness theory on rumination meditation and self efficacy of ST-segment elevation myocardial infarction patients after interventional therapy[J]. China Medical Herald, 2024, 21(10): 167-171.
    [7]
    张密, 马先莉. 基于协同护理模式的心脏康复对永久性起搏器植入患者自我管理行为、照顾者照顾能力的影响[J]. 国际护理学杂志, 2024, 43(6): 989-995.

    ZHANG M, MA X L. Effects of cardiac rehabilitation based on a collaborative care model on self-management behaviors, and caregiver caregiving abilities in patients with permanent pacemaker implants[J]. International Journal Of Nursing, 2024, 43(6): 989-995.
    [8]
    ARBELO E, PROTONOTARIOS A, GIMENO J R, et al. 2023 ESC Guidelines for the management of cardiomyopathies[J]. Eur Heart J, 2023, 44(37): 3503-3626.
    [9]
    郭晶晶, 袁河新, 张丹锋. 基于IMPACT模式的临床干预在冠心病患者中的应用及对预后的影响[J]. 中国循证心血管医学杂志, 2023, 15(1): 106-108.

    GUO J J, YUAN H X, ZHANG D F. Application of clinical intervention based on IMPACT mode and its influence on prognosis in patients with coronary heart disease[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine, 2023, 15(1): 106-108.
    [10]
    董忻悦, 张贤, 沈志云, 等. 扩张型心肌病护理实践规范[J]. 中国分子心脏病学杂志, 2023, 23(2): 5239-5249.

    DONG X Y, ZHANG X, SHEN Z Y, et al. Standard of practice on the care of dilated cardiomyopathy[J]. Molecular Cardiology of China, 2023, 23(2): 5239-5249.
    [11]
    HEYMANS S, LAKDAWALA N K, TSCHÖPE C, et al. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches[J]. Lancet, 2023, 402(10406): 998-1011. doi: 10.1016/S0140-6736(23)01241-2
    [12]
    ORPHANOU N, PAPATHEODOROU E, ANASTASAKIS A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments[J]. Heart Fail Rev, 2022, 27(4): 1173-1191. doi: 10.1007/s10741-021-10139-0
    [13]
    HARDING D, CHONG M H A, LAHOTI N, et al. Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy[J]. J Intern Med, 2023, 293(1): 23-47. doi: 10.1111/joim.13556
    [14]
    谭慧慧, 王宝华, 蒋辉. 扩张型心肌病合并肺动脉高压的危险因素及对预后的影响[J]. 中国循证心血管医学杂志, 2023, 15(12): 1353-1355.

    TAN H H, WANG B H, JIANG H. Risk factors of dilated cardiomyopathy complicated by pulmonary arterial hypertension and their influence on prognosis[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine, 2023, 15(12): 1353-1355.
    [15]
    李军, 胡泽平, 朱学涛. 扩张型心肌病患者心内血栓形成危险因素及预测模型研究[J]. 安徽医科大学学报, 2024, 59(4): 708-714.

    LI J, HU Z P, ZHU X T. Research on the risk factors and predictive model for intracardiac thrombosis in patients with dilated cardiomyopathy[J]. Acta Universitatis Medicinalis Anhui, 2024, 59(4): 708-714.
    [16]
    刘磊, 罗贵全, 刘溢均, 等. 老年扩张型心肌病并发恶性心律失常的危险因素与远期预后分析[J]. 中华全科医学, 2023, 21(6): 958-961. doi: 10.16766/j.cnki.issn.1674-4152.003024

    LIU L, LUO G Q, LIU Y J, et al. Risk factors and long-term prognosis of malignant arrhythmia in elderly patients with dilated cardiomyopathy[J]. Chinese Journal of General Practice, 2023, 21(6): 958-961. doi: 10.16766/j.cnki.issn.1674-4152.003024
    [17]
    田亚男. 左西孟旦联合认知行为疗法对扩张型心肌病合并慢性心力衰竭的效果分析[J]. 河北医药, 2022, 44(12): 1795-1798, 1803.

    TIAN Y N. The clinical efficacy of levosimendan combined with cognitive behavior therapy for patients with dilated cardiomyopathy complicated by chronic heart failure[J]. Hebei Medical Journal, 2022, 44(12): 1795-1798, 1803.
    [18]
    金佳敏, 巩倩, 庄乐南. 扩张型心肌病动物模型及治疗的研究进展[J]. 浙江大学学报(农业与生命科学版), 2024, 50(1): 1-11.

    JIN J M, GONG Q, ZHUANG L N. Advances in animal models and treatment of dilated cardiomyopathy[J]. Journal of Zhejiang University: Agriculture and Life Sciences, 2024, 50(1): 1-11.
    [19]
    杜家琦, 姚瑞, 郝正阳, 等. 外周血NLR、MHR对扩张型心肌病患者发生冠状动脉粥样硬化的影响及预测效能[J]. 山东医药, 2022, 62(9): 86-89.

    DU J Q, YAO R, HAO Z Y, et al. The influence and predictive efficacy of peripheral blood NLR and MHR on coronary atherosclerosis in patients with dilated cardiomyopathy[J]. Shandong Medical Journal, 2022, 62(9): 86-89.
    [20]
    屈江艳, 宋宝梅, 金茜, 等. 心率及个体化管理对老年扩张型心肌病患者心理状态及运动耐力的影响[J]. 老年医学与保健, 2022, 28(4): 851-855.

    QU J Y, SONG B M, JIN Q, et al. Effects of heart rate and individualized management on mental state and exercise endurance of elderly patients with dilated cardiomyopathy[J]. Geriatrics & Health Care, 2022, 28(4): 851-855.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (29) PDF downloads(0) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return